ZNF35
gene geneOn this page
Also known as HF.10HF10Zfp105
Summary
ZNF35 (zinc finger protein 35, HGNC:13099) is a protein-coding gene on chromosome 3p21.31, encoding Zinc finger protein 35 (P13682). May be involved in transcriptional regulation.
Enables DNA-binding transcription factor activity and sequence-specific DNA binding activity. Predicted to be involved in cellular response to retinoic acid; regulation of transcription by RNA polymerase II; and spermatogenesis. Located in nucleus and perinuclear region of cytoplasm.
Source: NCBI Gene 7584 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 1 total
- MANE Select transcript:
NM_003420
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:13099 |
| Approved symbol | ZNF35 |
| Name | zinc finger protein 35 |
| Location | 3p21.31 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | HF.10, HF10, Zfp105 |
| Ensembl gene | ENSG00000169981 |
| Ensembl biotype | protein_coding |
| OMIM | 194533 |
| Entrez | 7584 |
Gene structure
Transcript identifiers
Ensembl transcripts: 9 — 9 protein_coding
ENST00000296092, ENST00000396056, ENST00000399560, ENST00000415571, ENST00000432115, ENST00000453164, ENST00000865407, ENST00000865408, ENST00000921897
RefSeq mRNA: 1 — MANE Select: NM_003420
NM_003420
CCDS: CCDS2718
Canonical transcript exons
ENST00000396056 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001178523 | 44658701 | 44660791 |
| ENSE00001920360 | 44648732 | 44648834 |
| ENSE00003468552 | 44650941 | 44651259 |
| ENSE00003788954 | 44652557 | 44652701 |
Expression profiles
Bgee: expression breadth ubiquitous, 138 present calls, max score 85.96.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 9.0778 / max 208.2075, expressed in 1736 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 36339 | 8.8247 | 1736 |
| 202738 | 0.2531 | 109 |
Top tissues by expression
138 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 85.96 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 82.41 | gold quality |
| corpus callosum | UBERON:0002336 | 80.56 | gold quality |
| tonsil | UBERON:0002372 | 79.80 | gold quality |
| islet of Langerhans | UBERON:0000006 | 78.97 | gold quality |
| ganglionic eminence | UBERON:0004023 | 78.73 | gold quality |
| bone marrow cell | CL:0002092 | 78.68 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 78.18 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 77.62 | gold quality |
| stromal cell of endometrium | CL:0002255 | 77.35 | gold quality |
| calcaneal tendon | UBERON:0003701 | 77.29 | gold quality |
| colonic epithelium | UBERON:0000397 | 77.19 | gold quality |
| muscle tissue | UBERON:0002385 | 76.87 | gold quality |
| cortical plate | UBERON:0005343 | 76.53 | gold quality |
| urinary bladder | UBERON:0001255 | 75.35 | gold quality |
| bone marrow | UBERON:0002371 | 75.22 | gold quality |
| adrenal tissue | UBERON:0018303 | 74.82 | gold quality |
| sural nerve | UBERON:0015488 | 74.46 | gold quality |
| skeletal muscle organ | UBERON:0014892 | 74.37 | gold quality |
| muscle of leg | UBERON:0001383 | 74.25 | gold quality |
| ventricular zone | UBERON:0003053 | 74.22 | gold quality |
| gastrocnemius | UBERON:0001388 | 74.18 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 74.04 | gold quality |
| lower esophagus | UBERON:0013473 | 74.01 | gold quality |
| testis | UBERON:0000473 | 73.60 | gold quality |
| heart left ventricle | UBERON:0002084 | 73.59 | gold quality |
| endometrium | UBERON:0001295 | 73.51 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 73.45 | gold quality |
| heart | UBERON:0000948 | 73.30 | gold quality |
| left coronary artery | UBERON:0001626 | 73.25 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-GEOD-124858 | no | 59.25 |
| E-ANND-3 | no | 0.99 |
Regulation
Is transcription factor: yes
JASPAR motifs
| Motif | Name | Family |
|---|---|---|
| MA2333.1 | ZNF35 | More than 3 adjacent zinc fingers |
JASPAR matrix evidence (PMIDs): PMID:8477855
miRNA regulators (miRDB)
34 targeting ZNF35, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4531 | 99.99 | 69.70 | 3181 |
| HSA-MIR-3119 | 99.92 | 71.34 | 2390 |
| HSA-MIR-10527-5P | 99.91 | 72.28 | 3754 |
| HSA-MIR-9902 | 99.89 | 69.15 | 2250 |
| HSA-MIR-30A-3P | 99.87 | 69.74 | 2928 |
| HSA-MIR-30D-3P | 99.87 | 69.92 | 2917 |
| HSA-MIR-30E-3P | 99.87 | 69.68 | 2942 |
| HSA-MIR-4503 | 99.85 | 71.45 | 1869 |
| HSA-MIR-2052 | 99.79 | 69.37 | 2031 |
| HSA-MIR-7856-5P | 99.75 | 69.99 | 2901 |
| HSA-MIR-10393-3P | 99.72 | 66.56 | 961 |
| HSA-MIR-6801-5P | 99.72 | 66.50 | 981 |
| HSA-MIR-545-5P | 99.66 | 70.18 | 2308 |
| HSA-MIR-561-3P | 99.64 | 70.90 | 3647 |
| HSA-MIR-1827 | 99.63 | 68.57 | 3265 |
| HSA-MIR-4743-3P | 99.62 | 68.12 | 2095 |
| HSA-MIR-6751-5P | 99.56 | 64.99 | 1145 |
| HSA-MIR-3120-3P | 99.54 | 70.28 | 2669 |
| HSA-MIR-12131 | 99.48 | 68.72 | 1673 |
| HSA-MIR-1275 | 99.47 | 67.90 | 2749 |
| HSA-MIR-21-5P | 99.46 | 70.54 | 1035 |
| HSA-MIR-6507-3P | 99.35 | 67.32 | 1059 |
| HSA-MIR-590-5P | 99.25 | 70.76 | 930 |
| HSA-MIR-1911-3P | 99.15 | 66.17 | 528 |
| HSA-MIR-6877-3P | 98.98 | 65.83 | 560 |
| HSA-MIR-6819-3P | 98.95 | 65.57 | 572 |
| HSA-MIR-2355-5P | 98.83 | 65.51 | 1589 |
| HSA-MIR-6846-5P | 98.81 | 65.86 | 1121 |
| HSA-MIR-6848-5P | 98.81 | 65.49 | 1126 |
| HSA-MIR-6784-3P | 98.39 | 64.88 | 662 |
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Zfp105 | ENSMUSG00000057895 |
| rattus_norvegicus | Zfp105 | ENSRNOG00000079667 |
| drosophila_melanogaster | CG2712 | FBGN0024975 |
| drosophila_melanogaster | Phs | FBGN0036522 |
| drosophila_melanogaster | CG3281 | FBGN0260741 |
Paralogs (62): ZNF582 (ENSG00000018869), ZNF264 (ENSG00000083844), ZNF343 (ENSG00000088876), ZNF684 (ENSG00000117010), ZNF133 (ENSG00000125846), ZNF557 (ENSG00000130544), ZNF337 (ENSG00000130684), ZNF20 (ENSG00000132010), ZFP37 (ENSG00000136866), ZNF614 (ENSG00000142556), KRBOX4 (ENSG00000147121), ZNF599 (ENSG00000153896), ZNF19 (ENSG00000157429), ZNF589 (ENSG00000164048), PRDM9 (ENSG00000164256), ZNF180 (ENSG00000167384), ZNF558 (ENSG00000167785), ZNF778 (ENSG00000170100), ZNF439 (ENSG00000171291), ZNF440 (ENSG00000171295), ZNF556 (ENSG00000172000), ZNF554 (ENSG00000172006), ZNF596 (ENSG00000172748), ZNF80 (ENSG00000174255), ZNF266 (ENSG00000174652), ZNF25 (ENSG00000175395), ZNF77 (ENSG00000175691), ZNF169 (ENSG00000175787), ZNF404 (ENSG00000176222), ZNF491 (ENSG00000177599), ZNF620 (ENSG00000177842), ZNF619 (ENSG00000177873), ZNF875 (ENSG00000181666), ZNF329 (ENSG00000181894), ZFP90 (ENSG00000184939), ZNF566 (ENSG00000186017), ZNF529 (ENSG00000186020), ZNF749 (ENSG00000186230), ZNF555 (ENSG00000186300), ZNF70 (ENSG00000187792)
Protein
Protein identifiers
Zinc finger protein 35 — P13682 (reviewed: P13682)
Alternative names: Zinc finger protein HF.10
All UniProt accessions (4): P13682, C9J011, C9JGR2, C9JGS9
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation. Involved in cell differentiation and/or proliferation.
Subcellular location. Nucleus.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
RefSeq proteins (1): NP_003411* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
| IPR050758 | Znf_C2H2-type | Family |
Pfam: PF00096
UniProt features (26 total): zinc finger region 11, cross-link 10, region of interest 2, sequence conflict 2, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-P13682-F1 | 63.62 | 0.36 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (10): 20, 21, 99, 117, 125, 144, 158, 189, 214, 276
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 111 (showing top):
GOBP_CELLULAR_RESPONSE_TO_LIPID, BROWNE_HCMV_INFECTION_8HR_UP, GOBP_MALE_GAMETE_GENERATION, GOBP_CELLULAR_RESPONSE_TO_OXYGEN_CONTAINING_COMPOUND, PUJANA_CHEK2_PCC_NETWORK, GOBP_CELLULAR_RESPONSE_TO_RETINOIC_ACID, KOYAMA_SEMA3B_TARGETS_UP, SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM4, GOBP_RESPONSE_TO_OXYGEN_CONTAINING_COMPOUND, GOBP_RESPONSE_TO_LIPID, RYTTCCTG_ETS2_B, ELK1_01, GOBP_DEVELOPMENTAL_PROCESS_INVOLVED_IN_REPRODUCTION, GOBP_RESPONSE_TO_RETINOIC_ACID, DANG_BOUND_BY_MYC
GO Biological Process (4): regulation of DNA-templated transcription (GO:0006355), regulation of transcription by RNA polymerase II (GO:0006357), spermatogenesis (GO:0007283), cellular response to retinoic acid (GO:0071300)
GO Molecular Function (8): RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), DNA binding (GO:0003677), DNA-binding transcription factor activity (GO:0003700), zinc ion binding (GO:0008270), sequence-specific DNA binding (GO:0043565), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (3): nucleus (GO:0005634), perinuclear region of cytoplasm (GO:0048471), cytoplasm (GO:0005737)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| regulation of DNA-templated transcription | 2 |
| transcription cis-regulatory region binding | 2 |
| cellular anatomical structure | 2 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| transcription by RNA polymerase II | 1 |
| developmental process involved in reproduction | 1 |
| male gamete generation | 1 |
| response to retinoic acid | 1 |
| cellular response to lipid | 1 |
| cellular response to oxygen-containing compound | 1 |
| chromatin | 1 |
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| nucleic acid binding | 1 |
| transcription regulator activity | 1 |
| transition metal ion binding | 1 |
| DNA binding | 1 |
| binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
| cytoplasm | 1 |
| intracellular anatomical structure | 1 |
Protein interactions and networks
STRING
428 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF35 | ETS2 | P15036 | 447 |
| ZNF35 | SATB1 | Q01826 | 433 |
| ZNF35 | LEF1 | Q9UJU2 | 405 |
| ZNF35 | MEF2C | Q06413 | 403 |
| ZNF35 | ATF5 | Q9Y2D1 | 386 |
| ZNF35 | KAT8 | Q9H7Z6 | 383 |
| ZNF35 | NFATC4 | Q14934 | 381 |
| ZNF35 | GATA3 | P23771 | 356 |
| ZNF35 | NFIL3 | Q16649 | 354 |
| ZNF35 | TAF6L | Q9Y6J9 | 352 |
| ZNF35 | KCNJ8 | Q15842 | 349 |
| ZNF35 | NFE2 | Q16621 | 349 |
| ZNF35 | FAM221A | A4D161 | 337 |
| ZNF35 | ID2 | Q02363 | 309 |
| ZNF35 | USF2 | Q15853 | 302 |
IntAct
108 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ZNF35 | ARIH1 | psi-mi:“MI:0915”(physical association) | 0.590 |
| ZNF35 | ZGPAT | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF35 | CDR2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF35 | GOLGA2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF35 | GRIPAP1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF35 | MCC | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF35 | PICK1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF35 | NDEL1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF35 | PRKAR1B | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF35 | PIBF1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| GOLGA6L9 | ZNF35 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF35 | HOOK1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF35 | psi-mi:“MI:0915”(physical association) | 0.560 | |
| ZNF35 | MAP3K20 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF35 | HOOK2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF35 | ZBTB8A | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF35 | HOMER3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF35 | GEMIN4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF35 | PNMA1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF35 | CEP70 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF35 | CDR2L | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF35 | TRAF2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| FSD2 | ZNF35 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF35 | MYD88 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF35 | YJU2B | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF35 | ATPAF2 | psi-mi:“MI:0915”(physical association) | 0.560 |
BioGRID (50): ZNF35 (Reconstituted Complex), ZNF35 (Affinity Capture-MS), ZNF35 (Affinity Capture-MS), ZNF35 (Affinity Capture-MS), ZNF35 (Affinity Capture-MS), ARIH1 (Affinity Capture-MS), ZNF35 (Affinity Capture-RNA), ZNF35 (Two-hybrid), ZNF35 (Two-hybrid), ZNF35 (Two-hybrid), ZNF35 (Two-hybrid), ZNF35 (Two-hybrid), ZNF35 (Two-hybrid), ZNF35 (Two-hybrid), ZNF35 (Two-hybrid)
ESM2 similar proteins: A1L1L7, A3KN36, D3ZVT0, O43296, P08042, P13682, P16373, P17023, P17097, P52738, P85977, Q02975, Q12901, Q14590, Q14592, Q2M3W8, Q2VY69, Q4V8A8, Q571J5, Q5CZA5, Q5R7I8, Q5RB33, Q5RBX0, Q61751, Q61967, Q6GQR8, Q6PF04, Q6ZNG0, Q6ZS27, Q86Y25, Q8BFS8, Q8BQC8, Q8IZ26, Q8N782, Q8N9Z0, Q8R1D1, Q8TF47, Q8WTR7, Q96LW1, Q9BS31
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
1 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 1 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
587 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 3:44648835:G:GG | donor_gain | 1.0000 |
| 3:44658693:T:A | acceptor_gain | 1.0000 |
| 3:44658696:TTCA:T | acceptor_loss | 1.0000 |
| 3:44648826:C:G | donor_gain | 0.9900 |
| 3:44648830:GCACA:G | donor_gain | 0.9900 |
| 3:44648833:CA:C | donor_gain | 0.9900 |
| 3:44651251:G:GT | donor_gain | 0.9900 |
| 3:44652555:AGGGT:A | acceptor_gain | 0.9900 |
| 3:44658694:G:A | acceptor_gain | 0.9900 |
| 3:44658699:A:AG | acceptor_gain | 0.9900 |
| 3:44658699:AG:A | acceptor_gain | 0.9900 |
| 3:44658699:AGGT:A | acceptor_gain | 0.9900 |
| 3:44658700:G:GG | acceptor_gain | 0.9900 |
| 3:44658700:GG:G | acceptor_gain | 0.9900 |
| 3:44658700:GGT:G | acceptor_gain | 0.9900 |
| 3:44658700:GGTG:G | acceptor_gain | 0.9900 |
| 3:44650379:G:GG | donor_gain | 0.9800 |
| 3:44650938:CAGTA:C | acceptor_gain | 0.9800 |
| 3:44650939:AGTAG:A | acceptor_gain | 0.9800 |
| 3:44650940:GTA:G | acceptor_gain | 0.9800 |
| 3:44650940:GTAGG:G | acceptor_gain | 0.9800 |
| 3:44658700:GGTGC:G | acceptor_gain | 0.9800 |
| 3:44648833:CAGTG:C | donor_loss | 0.9700 |
| 3:44648834:AGTG:A | donor_loss | 0.9700 |
| 3:44648836:TGAGT:T | donor_loss | 0.9700 |
| 3:44648837:G:GG | donor_loss | 0.9700 |
| 3:44648838:AG:A | donor_loss | 0.9700 |
| 3:44650940:G:GA | acceptor_gain | 0.9700 |
| 3:44651255:AAAAG:A | donor_loss | 0.9700 |
| 3:44651256:AAAG:A | donor_loss | 0.9700 |
AlphaMissense
3509 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 3:44659088:G:C | R242P | 0.999 |
| 3:44659138:T:C | F259L | 0.999 |
| 3:44659140:C:A | F259L | 0.999 |
| 3:44659140:C:G | F259L | 0.999 |
| 3:44659157:T:C | L265P | 0.999 |
| 3:44659222:T:C | F287L | 0.999 |
| 3:44659224:C:A | F287L | 0.999 |
| 3:44659224:C:G | F287L | 0.999 |
| 3:44659241:T:C | L293P | 0.999 |
| 3:44659474:T:C | F371L | 0.999 |
| 3:44659476:T:A | F371L | 0.999 |
| 3:44659476:T:G | F371L | 0.999 |
| 3:44659558:T:C | F399L | 0.999 |
| 3:44659560:T:A | F399L | 0.999 |
| 3:44659560:T:G | F399L | 0.999 |
| 3:44659577:T:C | L405P | 0.999 |
| 3:44659642:T:C | F427L | 0.999 |
| 3:44659644:C:A | F427L | 0.999 |
| 3:44659644:C:G | F427L | 0.999 |
| 3:44659726:T:C | F455L | 0.999 |
| 3:44659728:C:A | F455L | 0.999 |
| 3:44659728:C:G | F455L | 0.999 |
| 3:44659810:T:C | F483L | 0.999 |
| 3:44659812:C:A | F483L | 0.999 |
| 3:44659812:C:G | F483L | 0.999 |
| 3:44659829:T:C | L489P | 0.999 |
| 3:44659894:T:C | F511L | 0.999 |
| 3:44659896:C:A | F511L | 0.999 |
| 3:44659896:C:G | F511L | 0.999 |
| 3:44659054:T:C | F231L | 0.998 |
dbSNP variants (sampled 300 via entrez): RS1000148749 (3:44655788 G>A), RS1000256620 (3:44653048 T>C), RS1000490268 (3:44652498 G>C), RS1000924911 (3:44647485 CA>C), RS1000953859 (3:44647912 A>G), RS1001384063 (3:44645509 T>C), RS1001415301 (3:44645764 C>G), RS1001660889 (3:44651817 A>T), RS1002387039 (3:44647100 T>A), RS1002416428 (3:44647409 C>G), RS1002737492 (3:44653778 G>A), RS1002850018 (3:44649074 A>G), RS1002930197 (3:44650414 C>G), RS1003422385 (3:44657477 A>G,T), RS1003564657 (3:44649300 G>T)
Disease associations
OMIM: gene MIM:194533 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST008103_52 | Bipolar disorder | 3.000000e-07 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
25 total (human), top 25 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Tobacco Smoke Pollution | increases expression | 2 |
| Valproic Acid | decreases expression | 2 |
| TAK-243 | increases sumoylation | 1 |
| triphenyl phosphate | affects expression | 1 |
| sodium arsenite | increases expression, affects cotreatment, increases abundance | 1 |
| manganese chloride | affects cotreatment, increases abundance, increases expression | 1 |
| 2-palmitoylglycerol | increases expression | 1 |
| Acetaminophen | increases expression | 1 |
| Air Pollutants | decreases expression, increases abundance | 1 |
| Arsenic | affects cotreatment, increases abundance, increases expression | 1 |
| Atrazine | decreases expression | 1 |
| Coal | decreases expression, increases abundance | 1 |
| Copper | decreases expression, affects binding | 1 |
| Disulfiram | affects binding, decreases expression | 1 |
| Estradiol | increases expression | 1 |
| Formaldehyde | decreases expression | 1 |
| Manganese | increases abundance, increases expression, affects cotreatment | 1 |
| Methotrexate | decreases expression | 1 |
| Silicon Dioxide | increases expression | 1 |
| Smoke | decreases expression, increases abundance | 1 |
| Urethane | increases expression | 1 |
| Okadaic Acid | increases expression | 1 |
| Copper Sulfate | decreases expression | 1 |
| Lactic Acid | decreases expression | 1 |
| Magnetite Nanoparticles | decreases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.